Buckeye guidelines injectafer
WebJul 1, 2024 · Injectafer® (ferric carboxymaltose injection) Document Number: IC-0312 Last Review Date: 07/01/2024 Date of Origin: 08/29/2024 ... To view the most recent and complete version of the Guidelines, go online to NCCN.org. Accessed June 2024. 9. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J WebInjectafer is indicated for treatment of iron deficiency anemia (IDA) in adult patients who have: ... KDIGO 2012 clinical practice guideline for evaluation and management of chronic kidney disease. Kidney International Supplements. January 2013; 3(1): 1-136. 3. KDIGO 2012 clinical practice guideline for anemia in chronic kidney disease.
Buckeye guidelines injectafer
Did you know?
WebInjectafer 15 mg/kg body weight up to a maximum of 1,000 mg intravenously may be administered as a single dose treatment course. For patients weighing less than 50 kg, the recommended dosage is Injectafer 15 mg/kg body weight intravenously in two doses separated by at least 7 days per course. Each mL of Injectafer contains 50 mg of … WebClinical Practice Guidelines (CPGs) and Preventive Care Guidelines are adopted by BCBSIL and are the foundation for selected Condition Management Programs. These guidelines are based on established evidence-based standards of care, publicized by specialty societies and national clinical organizations. These guidelines are updated at …
WebFor patients weighing less than 50 kg, the recommended dosage is Injectafer 15 mg/kg body weight intravenously in two doses separated by at least 7 days per course . Each mL of Injectafer... WebSep 22, 2024 · Injectafer is used in adults and pediatric patients 1 year of age and older to treat iron deficiency anemia (IDA) (a lack of red blood cells caused by having too little …
WebJan 1, 2024 · Learn about Buckeye Health Plan’s prescription drug coverage for members. Skip to Main Content. Join the millions of people who get their yearly flu shot. ... WebFerric carboxymaltose (Injectafer®) injection is an iron replacement product. FDA Approved Indication(s) Injectafer is indicated for treatment of iron deficiency anemia (IDA) in adult …
WebInjectafer administration to demonstrate need for additional therapy; and Patient does not have CKD; and One of the following: - Feraheme dose does not exceed 510 mg elemental iron per dose and 2.04g elemental iron per course - Injectafer dose does not exceed 750 mg elemental iron per dose and 1500mg elemental iron per course; and
WebInjectafer is intended for single-use only. Any unused drug remaining after injection must be discarded. Avoid extravasation of Injectafer since brown discoloration of the extravasation site may be long lasting. Monitor for extravasation. If extravasation occurs, discontinue the Injectafer administration at that site. 3 DOSAGE FORMS AND STRENGTHS dr \u0027sbodikinsWebInjectafer is a prescription iron replacement medicine administered only by or under the supervision of your healthcare provider. Injectafer is injected into your vein to treat iron deficiency anemia in adults and pediatric patients 1 year of age and older. dr\u0027s b auto incWeb6 rows · Recommended dosage for patients weighing less than 50 kg (110 lb ): Give Injectafer in two doses ... dr\u0026gwWebFor patients weighing less than 50 kg (110 lb): Give Injectafer in two doses separated by at least 7 days. Give each dose as 15 mg/kg body weight for a total cumulative dose not to exceed 1500 mg of iron per course. The dosage of Injectafer is expressed in mg of elemental iron. Each mL of Injectafer contains 50 mg of elemental iron. dr\u0027s bag drug listWebIntravenous ferric carboxymaltose (Ferinject ®; Injectafer ®) is a colloidal solution of nanoparticles which consist of a polynuclear iron (III)-(oxyhydr)oxide core stabilized by carboxymaltose and may be given as a single high-dose, 15-min infusion.This article reviews the clinical use of ferric carboxymaltose in various patient populations with iron … rat\\u0027s g3WebOct 1, 2024 · According to the guidelines of our Site of Administration for Infusion and Injectable Prescription Medications Medical Policy, the administration of the infusion and injectable therapy drugs listed in the policy in a hospital outpatient setting is considered not medically necessary except as follows: dr\u0027s best lumbrokinaseWebWhenever possible, Buckeye Health Plan adopts preventive and clinical practice guidelines that are published by nationally recognized organizations or government … dr \u0027slife